Documentdetail
ID kaart

doi:10.1007/s13629-023-00396-z...

Auteur
Poel, Henk G.
Langue
nl
Editor

Springer

Categorie

Urology

Jaar

2023

vermelding datum

07-06-2023

Metriek

Poel, Henk G., 2023, Werkdruk, wat gaan we doen?, Springer

Document

Openen

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Batoclimab as induction and maintenance therapy in patients with myasthenia gravis: rationale and study design of a phase 3 clinical trial
gravis myasthenia study clinical phase baseline improvement mg-adl 340 week trial placebo period mg maintenance qw